Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11372008
Blood factor monitoring assay and uses thereof
granted -
US 11365230
Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
granted -
US 11365394
Enhanced immune effector cells and use thereof
granted -
US 11357839
Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use
granted -
US 11352639
Gene therapy based on vector VTVAF17
granted -
US 11351177
Corticotropin releasing factor receptor antagonists
granted -
US 11345928
Modified immunization vectors
granted -
US 11344557
Corticotropin releasing factor receptor antagonists
granted -
US 11332727
Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector
granted -
US 11311549
Corticotropin releasing factor receptor antagonists
granted -
US 11299533
Purification of factor VIII subspecies
granted -
US 11286528
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
granted -
US 11273182
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
granted -
US 11274282
Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigen
granted -
US 11274294
TAL effector-mediated DNA modification
granted -
US 11266720
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
granted -
US 11267782
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
granted -
US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted -
US 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 11254739
Anti-human migration stimulating factor (MSF) and uses thereof
granted -
US 11254731
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11241478
Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)
granted -
US 11236100
Modulators of eukaryotic initiation factor 2B, compositions and methods
granted -
US 11225514
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
granted